ATE122567T1 - Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten. - Google Patents
Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten.Info
- Publication number
- ATE122567T1 ATE122567T1 AT91901711T AT91901711T ATE122567T1 AT E122567 T1 ATE122567 T1 AT E122567T1 AT 91901711 T AT91901711 T AT 91901711T AT 91901711 T AT91901711 T AT 91901711T AT E122567 T1 ATE122567 T1 AT E122567T1
- Authority
- AT
- Austria
- Prior art keywords
- nicotinic acid
- nicotinamide
- preparations containing
- insulin preparations
- pct
- Prior art date
Links
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 title abstract 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 title abstract 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
- 102000004877 Insulin Human genes 0.000 title abstract 2
- 108090001061 Insulin Proteins 0.000 title abstract 2
- 229940125396 insulin Drugs 0.000 title abstract 2
- 235000005152 nicotinamide Nutrition 0.000 title abstract 2
- 239000011570 nicotinamide Substances 0.000 title abstract 2
- 229960003966 nicotinamide Drugs 0.000 title abstract 2
- 235000001968 nicotinic acid Nutrition 0.000 title abstract 2
- 239000011664 nicotinic acid Substances 0.000 title abstract 2
- 229960003512 nicotinic acid Drugs 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK654389A DK654389D0 (da) | 1989-12-21 | 1989-12-21 | Laegemiddel |
| DK7190A DK7190D0 (da) | 1990-01-10 | 1990-01-10 | Laegemiddel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE122567T1 true ATE122567T1 (de) | 1995-06-15 |
Family
ID=26063239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91901711T ATE122567T1 (de) | 1989-12-21 | 1990-12-20 | Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5382574A (de) |
| EP (1) | EP0506792B1 (de) |
| JP (1) | JP3122128B2 (de) |
| AT (1) | ATE122567T1 (de) |
| AU (1) | AU641721B2 (de) |
| CA (1) | CA2070814A1 (de) |
| DE (1) | DE69019534T2 (de) |
| DK (1) | DK0506792T3 (de) |
| ES (1) | ES2072596T3 (de) |
| WO (1) | WO1991009617A1 (de) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3562195A (en) * | 1994-10-04 | 1996-04-26 | Novo Nordisk A/S | Preparations containing aspb28 human insulin and nicotinamide |
| US5830999A (en) * | 1995-01-26 | 1998-11-03 | Regents Of The University Of California | Stabilization of insulin through ligand binding interations |
| EP0880969A1 (de) * | 1997-05-28 | 1998-12-02 | Applied Research Systems ARS Holdings N.V. | Im physiologischem Medium schwerlösliche pharmazeutische Peptidezusammensetzungen |
| JP2002524514A (ja) * | 1998-09-17 | 2002-08-06 | イーライ・リリー・アンド・カンパニー | タンパク質製剤 |
| US6573237B2 (en) | 2001-03-16 | 2003-06-03 | Eli Lilly And Company | Protein formulations |
| CA2531988C (en) * | 2003-08-05 | 2016-06-28 | Novo Nordisk A/S | Novel insulin derivatives |
| US9737511B2 (en) * | 2004-05-24 | 2017-08-22 | Geoffrey C. GURTNER | Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux |
| JP2008500347A (ja) * | 2004-05-24 | 2008-01-10 | ニュー・ヨーク・ユニヴァーシティー | 高血糖症による血糖の急激な増加及び／又は急激な遊離脂肪酸流動の増加の病理学的影響の治療方法又は予防方法 |
| ES2371361T3 (es) * | 2005-12-28 | 2011-12-30 | Novo Nordisk A/S | Composiciones que comprenden una insulina acilada y zinc y método de producción de dichas composiciones. |
| JP5552046B2 (ja) | 2007-06-13 | 2014-07-16 | ノボ・ノルデイスク・エー／エス | インスリン誘導体を含有する薬学的製剤 |
| US10098857B2 (en) | 2008-10-10 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds |
| JP4959005B2 (ja) | 2008-10-30 | 2012-06-20 | ノボ・ノルデイスク・エー／エス | 毎日の注射頻度より少ないインスリン注射での真性糖尿病の治療 |
| US9018190B2 (en) | 2009-03-27 | 2015-04-28 | Adocia | Functionalized oligosaccharides |
| FR2943538B1 (fr) | 2009-03-27 | 2011-05-20 | Adocia | Formulation a action rapide d'insuline recombinante humaine |
| KR101775000B1 (ko) | 2009-06-26 | 2017-09-04 | 노보 노르디스크 에이/에스 | 인슐린, 니코틴아미드 및 아미노산을 포함하는 제제 |
| AU2013203134B2 (en) * | 2009-06-26 | 2016-05-12 | Novo Nordisk A/S | Preparation comprising insulin, nicotinamide and an amino acid |
| DK2632478T3 (da) | 2010-10-27 | 2019-10-07 | Novo Nordisk As | Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller |
| KR20140030125A (ko) | 2010-12-14 | 2014-03-11 | 노보 노르디스크 에이/에스 | 인슐린, 니코틴아미드 및 아미노산을 포함하는 제제 |
| WO2012080320A1 (en) | 2010-12-14 | 2012-06-21 | Novo Nordisk A/S | Fast-acting insulin in combination with long-acting insulin |
| US20130231281A1 (en) | 2011-11-02 | 2013-09-05 | Adocia | Rapid acting insulin formulation comprising an oligosaccharide |
| WO2013130935A1 (en) * | 2012-03-02 | 2013-09-06 | Genentech, Inc. | Amido-benzyl sulfoxide derivatives |
| WO2013130943A1 (en) * | 2012-03-02 | 2013-09-06 | Genentech, Inc. | Alkyl-and di-substituted amido-benzyl sulfonamide derivatives |
| JP6224586B2 (ja) * | 2012-07-10 | 2017-11-01 | 武田薬品工業株式会社 | 注射用製剤 |
| CN104902922B (zh) | 2012-11-13 | 2017-12-12 | 阿道恰公司 | 包含经取代阴离子化合物的速效胰岛素制剂 |
| EP2991672A1 (de) | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Neuartiges verabreichungsschema |
| WO2015120457A1 (en) * | 2014-02-10 | 2015-08-13 | Biodel Inc. | Stabilized ultra-rapid-acting insulin formulations |
| AR099569A1 (es) * | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
| US20170028031A1 (en) * | 2014-03-07 | 2017-02-02 | Klavs Holger Jørgensen | Novel fast acting insulin preparations |
| FR3020947B1 (fr) | 2014-05-14 | 2018-08-31 | Adocia | Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations |
| US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
| US20190010206A1 (en) * | 2015-08-25 | 2019-01-10 | Novo Nordisk A/S | Novel Insulin Derivatives and the Medical Uses Hereof |
| ES2908373T3 (es) * | 2015-08-25 | 2022-04-28 | Novo Nordisk As | Nuevos derivados de insulina y los usos médicos de los mismos |
| FR3043557B1 (fr) | 2015-11-16 | 2019-05-31 | Adocia | Composition a action rapide d'insuline comprenant un citrate substitue |
| GB201607918D0 (en) | 2016-05-06 | 2016-06-22 | Arecor Ltd | Novel formulations |
| JP2019529506A (ja) | 2016-09-29 | 2019-10-17 | アレコル リミテッド | 新規の製剤 |
| EP3574007A1 (de) | 2017-01-30 | 2019-12-04 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Neuartiger igfr-like-2-rezeptor und verwendungen davon |
| GB201707188D0 (en) | 2017-05-05 | 2017-06-21 | Arecor Ltd | Novel formulations |
| GB201707187D0 (en) | 2017-05-05 | 2017-06-21 | Arecor Ltd | Novel formulations |
| GB201707189D0 (en) | 2017-05-05 | 2017-06-21 | Arecor Ltd | Novel formulations |
| WO2019055490A1 (en) | 2017-09-14 | 2019-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | PACKAGING OF IRRADIED FABRIC FOR FAT GREETING RETENTION |
| US12357562B2 (en) | 2018-04-04 | 2025-07-15 | Arecor Limited | Injection pen system for the delivery of an insulin compound |
| KR102833828B1 (ko) | 2018-04-04 | 2025-07-15 | 아레콜 리미티드 | 인슐린 화합물의 전달을 위한 의료용 주입 펌프 시스템 |
| US20210113763A1 (en) | 2018-04-04 | 2021-04-22 | Arecor Limited | Medical infusion pump system for the delivery of an insulin compound |
| TWI829687B (zh) | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
| FR3083985A1 (fr) | 2018-07-23 | 2020-01-24 | Adocia | Dispositif pour injecter une solution d'insuline(s) |
| WO2019243627A1 (fr) | 2018-06-23 | 2019-12-26 | Adocia | Dispositif pour injecter une solution d'insuline(s) |
| FR3083984A1 (fr) | 2018-07-23 | 2020-01-24 | Adocia | Dispositif pour injecter une solution d'insuline(s) |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| US12343383B2 (en) | 2019-07-12 | 2025-07-01 | Novo Nordisk A/S | High concentration insulin formulation |
| DK4073097T3 (da) | 2019-12-11 | 2024-08-19 | Novo Nordisk As | Nye insulinanaloger og anvendelser heraf |
| GB202004814D0 (en) | 2020-04-01 | 2020-05-13 | Arecor Ltd | Novel formulations |
| AR131148A1 (es) | 2022-11-26 | 2025-02-19 | Obshchestvo S Ogranichennoy Otvetstvennostyu «Geropharm» | Composiciones de insulina de acción rápida (variantes de las mismas) |
| CN120676958A (zh) | 2022-12-04 | 2025-09-19 | 吉洛法姆有限责任公司 | 门冬胰岛素组合物（实施方式） |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2179384A (en) * | 1937-04-05 | 1939-11-07 | Univ Alberta | Therapeutic composition and process of making it |
| US2538018A (en) * | 1944-04-04 | 1951-01-16 | Nordisk Insulinlab | Crystalline product of insulin and alkaline protein and process of making it |
| US2793977A (en) * | 1951-08-31 | 1957-05-28 | Caspe Saul | Compositions and method for reducing blood sugar concentration |
| DK116527B (da) * | 1967-03-01 | 1970-01-19 | Nordisk Insulinlab | Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse. |
| GB1603639A (en) * | 1978-05-26 | 1981-11-25 | Haggar H | Composition for application to the hair and scalp |
| CA1299102C (en) * | 1987-06-15 | 1992-04-21 | Steven G. Ayre | Insulin potentiation therapy |
| US5155096A (en) * | 1987-06-15 | 1992-10-13 | Garcia Y Bellon Donato P | Method for potentiation of a therapeutic agent |
| EP0339054B1 (de) * | 1987-10-08 | 1994-07-06 | Andor Bilas | Stoffgemisch zur stabilisierung der stoffwechsel-lage |
-
1990
- 1990-12-20 JP JP03502033A patent/JP3122128B2/ja not_active Expired - Fee Related
- 1990-12-20 EP EP91901711A patent/EP0506792B1/de not_active Expired - Lifetime
- 1990-12-20 DK DK91901711.1T patent/DK0506792T3/da active
- 1990-12-20 WO PCT/DK1990/000335 patent/WO1991009617A1/en not_active Ceased
- 1990-12-20 CA CA002070814A patent/CA2070814A1/en not_active Abandoned
- 1990-12-20 DE DE69019534T patent/DE69019534T2/de not_active Expired - Fee Related
- 1990-12-20 US US07/849,448 patent/US5382574A/en not_active Expired - Fee Related
- 1990-12-20 AU AU70471/91A patent/AU641721B2/en not_active Ceased
- 1990-12-20 AT AT91901711T patent/ATE122567T1/de not_active IP Right Cessation
- 1990-12-20 ES ES91901711T patent/ES2072596T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK0506792T3 (da) | 1995-10-09 |
| EP0506792B1 (de) | 1995-05-17 |
| JP3122128B2 (ja) | 2001-01-09 |
| WO1991009617A1 (en) | 1991-07-11 |
| CA2070814A1 (en) | 1991-06-22 |
| EP0506792A1 (de) | 1992-10-07 |
| AU641721B2 (en) | 1993-09-30 |
| AU7047191A (en) | 1991-07-24 |
| ES2072596T3 (es) | 1995-07-16 |
| US5382574A (en) | 1995-01-17 |
| JPH05502234A (ja) | 1993-04-22 |
| DE69019534D1 (de) | 1995-06-22 |
| DE69019534T2 (de) | 1995-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE122567T1 (de) | Insulinzubereitungen, die nikotinsäure oder nikotinamid enthalten. | |
| GR3021937T3 (en) | Injection and injection kit containing omeprazole and its analogs. | |
| CS960586A2 (en) | Insekticidni a akaricidni prostredek a zpusob vyroby ucinnych latek | |
| PH31617A (en) | Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds. | |
| ES2102388T3 (es) | Polidextrosa modificada y procedimiento para su preparacion. | |
| NO880558D0 (no) | Pyridin-2,4- og 2,5-dikarboksylsyreamider, samt fremgangsmaate for fremstilling derav. | |
| AU5073385A (en) | N-((4,6-dimethoxypyrimidin-2-YL)Aminocarbonyl)-3- trifluoromethylpridine-2-sulfonamide or salts thereof, herbicidal composition containing the same, and process for the production of the compound | |
| DK165877C (da) | 1,4-dihydro-6-fluor-4-oxo-1,8-naphthyridin-3-carboxylsyrederivater og salte deraf, antibakterielle praeparater indeholdende saadanne forbindelser | |
| ATE71771T1 (de) | Kupferoxid-supraleiter mit gemischter wertigkeit und verfahren zu seiner herstellung. | |
| DK0589995T3 (da) | Hidtil ukendte polypeptider og deres anvendelse | |
| DK0533790T3 (da) | Hidtil ukendt saltform af 5-difluormethoxy-2-((3,4-dimethoxy-2-pyridyl)methylsulfinyl)-1H-benzimidazol | |
| ATE10156T1 (de) | An elementen reiche zusammensetzung. | |
| EP0224842A3 (en) | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | |
| KR900701798A (ko) | 리파펜틴(Rifapentine) 할로겐산염류 | |
| HU9301678D0 (en) | Method for producing substituted 4-amino-5-(alkyl-thio)-1,2,3-thiazole-3-one derivatives and herbicidal preparatives containing them as active substance | |
| ES2037838T3 (es) | Derivados de eritromicina a modificados en c-12. | |
| DE69009823D1 (de) | Zusammensetzungen, die 2-Thiocyanomethylthiobenzothiazol enthalten. | |
| BR9205255A (pt) | Aril aquil esteres de acido 4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antraceno carboxilico com atividade terapeutica | |
| PT83648A (fr) | Procede de preparation de compositions herbicides contenant n-(2,4-difluorophenyl)-2-(3-trifluoromethylphenoxy)-nicotinamide (diflufenican) | |
| ES2013025A6 (es) | Un metodo para preparar 24r-escimnol. | |
| EP0414216A3 (en) | Cyclic pyridin-2,4- and 2,5-dicarboxylic acid diamides, process for their preparation and their use | |
| ES8707706A1 (es) | Un procedimiento para la preparacion de nuevos derivados de propanodiona. | |
| MD950100A (en) | Substituted oximethers method of their preparation and application for pests and fungus control | |
| DK621688A (da) | Ethylerede avermectiner og praeparater indeholdende disse til behandling og forhindring af parasitinfektioner hos mennesker og dyr | |
| ES548791A0 (es) | Un procedimiento para preparar una sal de metal alcalino o alcalino-terreo de 5-cianopiridin-2-diazohidroxido |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |